A COVID-19 vaccine isn't the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.
As ready as you are to be done with COVID-19, it's not going anywhere soon. A historian of disease describes how once a pathogen emerges, it's usually here to stay.
A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
Patients suffering from severe COVID-19 may be experiencing a rogue antibody response similar to that seen in autoimmune diseases. The findings offer new approaches for COVID-19 therapy.
This isn't the first time America's schoolchildren have studied remotely – and Chicago's 1937 'radio school' experiment shows how technology can fill the gap during a crisis.
The president and first lady Melania Trump have both tested positive for the coronavirus. Here's what the physicians and scientists know about the best treatments for the disease it causes.
Older coronavirus patients face grimmer outlooks. A virologist explains the aging-related changes in how immune systems work that are to blame.
The Trump administration wants to go it alone when it comes to vaccine development and distribution. What does this mean for the U.S. and the world?
Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.
Children struggle amidst adversity, but these tumultuous and highly emotional times make it a critical time to teach 'resilience' – giving kids coping skills.
A new test, which can diagnose COVID-19 in 15 minutes, has been approved by the TGA. But it's no silver bullet.
Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?
There's a targeted subunit protein vaccine, an mRNA vaccine, and a needle-free DNA vaccine. Here's what that all means.
The SARS-CoV-2 virus usually infects the body via the ACE2 protein. But there is another entry point that allows the virus to infect the nervous system and block pain perception.
Some insights into previous outbreaks of human coronaviruses may be useful in explaining the comparatively 'low' numbers of COVID-19 infections and mortality in people with HIV in South Africa.
Governments must embrace policies that promote sharing and collective invention to create and distribute a vaccine quickly.
A preliminary study published online this week estimates Australia had 60,000 undiagnosed COVID-19 infections by July. But there are a range of limitations to the study.
Wearing face masks may allow a tiny number of viral particles to slip through, possibly allowing our body to gain some sort of immunity.
A tragic error showed how complicated it can be to distribute vaccines on a mass scale.
Using random testing, researchers in Indiana were able to calculate death rates by age, race, and sex and found sharp increases in risk of death among older and non-white state residents.